TORONTO, Nov. 8, 2021 /CNW/ - Michael Wright, President and Chief Executive
Officer, NuGen Medical Devices Inc., ("NuGen" or the "Company")
(TSXV: NGMD) and his team joined Arne
Gulstene, Head of TSX Company Services, TMX Group, to
celebrate the Company's new listing on the TSX Venture Exchange and
open the market.
NuGen Medical Devices is an emerging specialty medical device
company focused on developing and commercializing novel drug
delivery technologies. NuGen Medical Devices' principal business is
the research, development and commercialization of innovative
needle-free injection devices and systems for the administration of
subcutaneous medication. It is developing products using
needle-free drug delivery technology in several important fields
including, but not limited to, anaphylaxis, diabetes, severe
migraine, erectile dysfunction, chronic anaemia, neutropenia,
autoimmune rheumatoid arthritis, growth and fertility hormone,
psoriasis as well as DNA and conventional/pediatric vaccines.
For Market Openings: Media may pick up a feed
from the TOC (television operations centre) for all market open
ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is
produced at the TMX Broadcast Centre and sent live to the TOC. To
pick up the feed via the Dejero network, please contact
avservices@tmx.com. The client feature video will begin playing on
the TMX media wall at approximately 9:27
a.m. ET and the markets will open with the sound of a siren
at 9:30 a.m. ET
Date: Monday, November 8,
2021
Time: 9:00am -
9:30am
Place: Virtually Broadcast
SOURCE TSX Venture Exchange